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Acute Stent Thrombosis: Technical Complication
or Inadequate Antithrombotic Therapy?
An Optical Coherence Tomography Study
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grantA 68-year-old woman was admitted to the hospital
with non–ST-segment elevation myocardial in-
farction. Coronary angiography showed a 95% mid
stenosis in the left anterior descending artery
(Fig. 1A). The lesion was treated with a 2.50 
18-mm Xience drug-eluting stent (Abbott Vascular,
Santa Clara, California) during bivalirudin infusion
(Fig. 1B). At the end of the procedure, the patient
received a 600-mg loading dose of clopidogrel and
bivalirudin was discontinued. Seventy minutes later,
the patient experienced chest pain with anterior
ST-segment elevations. Repeat angiography demon-
strated acute stent thrombosis (AST) (Fig. 2A).
While the patient was on heparin and eptifibatide,
low-pressure angioplasty was performed. Optical
coherence tomography (OCT) imaging revealed
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thrombus within the stent (Figs. 2B).
Technical factors or inadequate antithrombotic
therapies are responsible for AST (1,2). In this case,
mechanical complications such as dissection, under-
expansion, or significant malapposition were ruled
out. Review of the timing of antithrombotic therapy
revealed possible gaps in therapy. Bivalirudin was
discontinued simultaneous to the administration of
clopidogrel. Clinical effects of bivalirudin con-
tinue for 1 h after its discontinuation, whereas
the anticipated onset of clopidogrel (600 mg)
effect is 2 h after its administration (3). Conse-
quently, antithrombotic therapy in our patient
was insufficient for approximately 1 h, during
which the AST occurred (Fig. 3).
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OCT for Acute Stent Thrombosis
e4Our case highlights the usefulness of OCT in evaluating
underlying mechanisms for AST and in characterizing
thrombus composition (platelets). Additionally, it empha-
sizes the significant increase in ischemic events with bivali-
rudin in subjects not pre-treated with clopidogrel (2,4).
are is needed to ensure sufficient antithrombotic therapy
n these patients with the use of rapidly acting antithrom-
otic agents, prolongation of bivalirudin infusion, or earlier
dministration of the clopidogrel loading dose.
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Figure 2. Evaluation of AST
(A) Repeat coronary angiography 1 h after the initial procedure demonstrated
ence tomography imaging demonstrated adequate stent expansion and the a
stented lumen.
Figure 3. Timeline of Antithrombotic Therapy and Stent Thrombosis
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